Giorgio Amendola

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Journal of chemical information and modeling

Journal of enzyme inhibition and medicinal chemistry

Università degli studi della Campania Luigi Vanvitelli Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli studi della Campania Luigi Vanvitelli Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche

Italy

PhD student :: DISTABIF

Publications

Michele Roggia, Benito Natale, Giorgio Amendola, Nicola Grasso, Salvatore Di Maro, Sabrina Taliani, Sabrina Castellano, Serena Concetta Rita Reina, Erica Salvati, Jussara Amato, Sandro Cosconati
Discovering Dually Active Anti-cancer Compounds with a Hybrid AI-structure-based Approach. Journal of chemical information and modeling (2024)
Michele Roggia, Benito Natale, Giorgio Amendola, Salvatore Di Maro, Sandro Cosconati
Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach. Journal of chemical information and modeling (2023)
Valentina Albanese, Chiara Ruzza, Erika Marzola, Tatiana Bernardi, Martina Fabbri, Anna Fantinati, Claudio Trapella, Rainer K Reinscheid, Federica Ferrari, Chiara Sturaro, Girolamo Calò, Giorgio Amendola, Sandro Cosconati, Salvatore Pacifico, Remo Guerrini, Delia Preti
Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity. Journal of medicinal chemistry 64 (7) (2021)
Giorgio Amendola, Sandro Cosconati
PyRMD: A New Fully Automated AI-Powered Ligand-Based Virtual Screening Tool. Journal of chemical information and modeling 61 (8) (2021)
Giorgio Amendola, Roberta Ettari, Santo Previti, Carla Di Chio, Anna Messere, Salvatore Di Maro, Stefan J Hammerschmidt, Collin Zimmer, Robert A Zimmermann, Tanja Schirmeister, Maria Zappalà, Sandro Cosconati
Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening. Journal of chemical information and modeling 61 (4) (2021)
Antonella Messore, Angela Corona, Valentina Noemi Madia, Francesco Saccoliti, Valeria Tudino, Alessandro De Leo, Davide Ialongo, Luigi Scipione, Daniela De Vita, Giorgio Amendola, Ettore Novellino, Sandro Cosconati, Mathieu Métifiot, Marie-Line Andreola, Francesca Esposito, Nicole Grandi, Enzo Tramontano, Roberta Costi, Roberto Di Santo
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase. Journal of medicinal chemistry 64 (12) (2021)
Stamatia Zavitsanou, Alexandros Tsengenes, Michail Papadourakis, Giorgio Amendola, Alexios Chatzigoulas, Dimitris Dellis, Sandro Cosconati, Zoe Cournia
FEPrepare: A Web-Based Tool for Automating the Setup of Relative Binding Free Energy Calculations. Journal of chemical information and modeling 61 (9) (2021)
Ciro Milite, Giorgio Amendola, Alessio Nocentini, Silvia Bua, Alessandra Cipriano, Elisabetta Barresi, Alessandra Feoli, Ettore Novellino, Federico Da Settimo, Claudiu T Supuran, Sabrina Castellano, Sandro Cosconati, Sabrina Taliani
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)
Ciro Milite, Alessandra Feoli, John R Horton, Donatella Rescigno, Alessandra Cipriano, Vincenzo Pisapia, Monica Viviano, Giacomo Pepe, Giorgio Amendola, Ettore Novellino, Sandro Cosconati, Xiaodong Cheng, Sabrina Castellano, Gianluca Sbardella
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure. Journal of medicinal chemistry 62 (5) (2019)
Roberta Ettari, Santo Previti, Santina Maiorana, Giorgio Amendola, Annika Wagner, Sandro Cosconati, Tanja Schirmeister, Ute A Hellmich, Maria Zappalà
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis. Journal of medicinal chemistry 62 (23) (2019)
Silvia Salerno, Elisabetta Barresi, Giorgio Amendola, Emanuela Berrino, Ciro Milite, Anna Maria Marini, Federico Da Settimo, Ettore Novellino, Claudiu T Supuran, Sandro Cosconati, Sabrina Taliani
4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors. Journal of medicinal chemistry 61 (13) (2018)
Santo Previti, Roberta Ettari, Sandro Cosconati, Giorgio Amendola, Khawla Chouchene, Annika Wagner, Ute A Hellmich, Kathrin Ulrich, R Luise Krauth-Siegel, Peter Richard Wich, Ira Schmid, Tanja Schirmeister, Jiri Gut, Philip J Rosenthal, Silvana Grasso, Maria Zappalà
Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs). Journal of medicinal chemistry 60 (16) (2017)
Floriana Morgillo, Giorgio Amendola, Carminia Maria Della Corte, Chiara Giacomelli, Lorenzo Botta, Salvatore Di Maro, Anna Messere, Vincenza Ciaramella, Sabrina Taliani, Luciana Marinelli, Maria Letizia Trincavelli, Claudia Martini, Ettore Novellino, Fortunato Ciardiello, Sandro Cosconati
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer. Journal of medicinal chemistry 60 (17) (2017)

Giorgio Amendola.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giorgio Amendola